The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women With Type 2 Diabetes: A Randomized Clinical Trial

• by Aiden V Brossfield, Donald J McMahon, Jason Fernando, Beatriz Omeragic, Rukshana Majeed, Sanchita Agarwal, Grazyna E Sroga, Bowen Wang, Deepak Vashishth, Mishaela R Rubin

• October 8, 2024

Utilizing Machine Learning to Identify Risk Factors for Diabetic Microvascular Complications and Develop a Predictive Model with Gradient Boosting Decision Trees

• by Min Xiao, Yuhao Fu, Yan Li, Qian Liu, Xianyi Qiao, Hongjin Zhang, Xingxing Zhu, Jiajia Wang

• April 21, 2026

New Strategies for Managing Diabetic Retinopathy

• by Omar Saeed, MPH, Veeral S. Sheth, MD, MBA, FACS

• May 1, 2026

• 12 min

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min